DAX24.215 ±-0,0%ESt505.380 +0,5%Top 10 Crypto16,25 +2,1%Dow44.902 +0,5%Nas21.108 +0,2%Bitcoin101.935 +0,3%Euro1,1663 -0,7%Öl69,42 +1,5%Gold3.337 ±-0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Volkswagen (VW) vz. 766403 RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Bayer BAY001 Lufthansa 823212 Deutsche Bank 514000 BASF BASF11 Porsche PAG911 DroneShield A2DMAA Tesla A1CX3T Novo Nordisk A3EU6F Deutsche Telekom 555750 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-EU-Zolldeal im Blick: DAX stabil -- NVIDIA-Aktie: Huawei stellt Konkurrenzsystem vor -- NEL, Amazon, Clara Tech, D-Wave, LVMH, Bayer, BASF, PUMA, Rüstungsaktien, Intel im Fokus
Top News
Nordex-Aktie klar fester: Nordex erreicht Markterwartung bei Marge - Prognose bestätigt Nordex-Aktie klar fester: Nordex erreicht Markterwartung bei Marge - Prognose bestätigt
Aktienempfehlung Merck-Aktie: Bernstein Research bewertet Anteilsschein in neuer Analyse Aktienempfehlung Merck-Aktie: Bernstein Research bewertet Anteilsschein in neuer Analyse
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Ãœbersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Rocket Pharmaceuticals Aktie

Handeln
Aktien-Sparplan anlegen
2,67 EUR +0,03 EUR +0,95 %
DUS
3,14 USD -0,08 USD -2,33 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.288,50 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2JA9Q

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS77313F1066

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolRCKT

Rocket Pharmaceuticals Aktien News

DatumMeistgelesen
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
PR NewswireSHAREHOLDER ALERT: Berger Montague Reminds Rocket Pharmaceuticals (NASDAQ: RCKT) Investors of Class Action Lawsuit Deadline
Wer­bungRocket Pharmaceuticals-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
PR NewswireATTENTION NASDAQ: RCKT INVESTORS: Contact Berger Montague About a Rocket Pharmaceuticals Class Action Lawsuit
PR NewswireLevi & Korsinsky Reminds Rocket Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
PR NewswireRocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rocket Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - RCKT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT
PR NewswireShareholders that lost money on Rocket Pharmaceuticals, Inc.(RCKT) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT
PR NewswireRCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireContact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc.(RCKT)
PR NewswireRCKT INVESTOR ALERT: Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead the Rocket Pharmaceuticals Class Action Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT
PR NewswireShareholder Alert: Robbins LLP Informs Investors of the Rocket Pharmaceuticals, Inc. Class Action
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT
BenzingaThese Analysts Slash Their Forecasts On Rocket Pharmaceuticals
ZacksRocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus
ZacksRocket Pharmaceuticals (RCKT) Loses -12.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZacksRocket Pharmaceuticals (RCKT) Down 10.6% Since Last Earnings Report: Can It Rebound?
PR NewswireEQUITY ALERT: The M&A Class Action Firm Continues Investigating the Merger -SPNE, PEBO, SBCF, RCKT
PR NewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBCF, RCKT, CLR, USER
PR NewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, RCKT, RMED, RCOR
PR NewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STOR, RCKT, RCOR, FCRD
PR NewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EQ, MTCR, STOR, RCKT
PR NewswireThe M&A Class Action Firm Announces an Investigation of Renovacor, Inc. - RCKT

Rocket Pharmaceuticals News

Rocket Pharmaceuticals News: auf dieser Seite finden Sie alle Rocket Pharmaceuticals News und Nachrichten zur Rocket Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Rocket Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Rocket Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.